New Product Development

Talecris continues to leverage research and development strengths to seek additional co-development partners and further strengthen our product pipeline. Working together, Talecris and our strategic development partners allow Talecris innovations to reach even more patients around the world.


Emergent BioSolutions — An exclusive manufacture and supply agreement between Talecris Biotherapeutics and Emergent BioSolutions involves the development of a new immunoglobulin for inclusion in the national stockpile for the treatment of anthrax exposure.